Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Brepco Biopharma

Brepco Biopharma?uq=UG6efJS6
2008 FOUNDED
PRIVATE STATUS
M&A LATEST DEAL TYPE (Cancelled)
2 FINANCING ROUNDS
Description

Operator of a healthcare company. The company focuses on developing products for the unique needs of pediatric or other vulnerable patient populations. It also provides pediatric formulation of an inotrope that is used to treat hypotension in critically ill babies and children.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Primary Office
  • The Avenue, Beacon Court
  • Suite 1
  • Dublin 18
  • Ireland

+353 087 000 0000

Brepco Biopharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Brepco Biopharma‘s full profile, request access.

Request full access to PitchBook

Brepco Biopharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Brepco Biopharma‘s full profile, request access.

Request full access to PitchBook

Brepco Biopharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Seamus O'Loan Chief Executive Officer
Paul Breen Co-Founder, Chairman & Director

Brepco Biopharma Board Members (1)

Name Representing Role Since Contact
Info
0000 00000 Brepco Biopharma Co-Founder, Chairman & Director 000 0000